“For the first time, we have the full picture of the value of medical technologies to Australian patients, the healthcare system, and the economy. What is clear, is that we are a nation that embraces medical innovation – and our patients are the beneficiaries," said CEO Ian Burgess. …
New report highlights the potential gains from earlier access to medical technologies
June 20, 2023 Latest NewsBioPharma
Latest Video
New Stories
-
Mesoblast says Ryoncil payer coverage extended to over 100 million Americans
April 22, 2025 - - Australian Biotech -
Anatara provides update following completion of analysis of Phase 2 GaRP-IBS clinical trial
April 22, 2025 - - Australian Biotech -
Recce Phase 2 trial receives additional approval for treating diabetic patients with topical gel
April 22, 2025 - - Australian Biotech -
Race says patient enrolment opened at second site for RC220 solid tumour trial
April 22, 2025 - - Australian Biotech -
Neurizon announces the appointment of chief financial officer
April 22, 2025 - - BioPharmaDispatch Executive -
Australia increasingly isolated after Europe approves Alzheimer's therapy
April 22, 2025 - - BioPharma -
Pharmac proposes three-monthly quantities for popular asthma inhalers
April 22, 2025 - - Latest News